Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Perimeter Medical Imaging AI Inc V.PINK

Alternate Symbol(s):  PYNKF

Perimeter Medical Imaging AI, Inc. is a medical technology company driven to transform cancer surgery with resolution, real-time, imaging tools to address high unmet medical needs. It develops and commercializes in-procedural medical imaging tools. The Company’s Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue... see more

TSXV:PINK - Post Discussion

View:
Post by WhiteknightA on Apr 29, 2021 8:20pm

Qtr4/year end

They are set to release their Qtr4 and 2020 year end financials soon. I'm guessing that's why there has been a sell off as of late. Assuming the reports won't be pretty. Also they do intend to list on the nasdaq which I feel is a very promising reason to hold the stock alone.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities